- Home
- CISO vs ASBP Comparison
CISO vs ASBP Comparison
Compare CISO & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- ASBP
- Stock Information
- Founded
- CISO 2015
- ASBP 2021
- Country
- CISO United States
- ASBP United States
- Employees
- CISO N/A
- ASBP N/A
- Industry
- CISO Computer Software: Prepackaged Software
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- ASBP Health Care
- Exchange
- CISO Nasdaq
- ASBP Nasdaq
- Market Cap
- CISO 31.4M
- ASBP 26.6M
- IPO Year
- CISO N/A
- ASBP N/A
- Fundamental
- Price
- CISO $1.29
- ASBP $0.42
- Analyst Decision
- CISO
- ASBP
- Analyst Count
- CISO 0
- ASBP 0
- Target Price
- CISO N/A
- ASBP N/A
- AVG Volume (30 Days)
- CISO 610.4K
- ASBP 28.4M
- Earning Date
- CISO 08-14-2025
- ASBP 08-13-2025
- Dividend Yield
- CISO N/A
- ASBP N/A
- EPS Growth
- CISO N/A
- ASBP N/A
- EPS
- CISO N/A
- ASBP N/A
- Revenue
- CISO $28,792,765.00
- ASBP N/A
- Revenue This Year
- CISO N/A
- ASBP N/A
- Revenue Next Year
- CISO N/A
- ASBP N/A
- P/E Ratio
- CISO N/A
- ASBP N/A
- Revenue Growth
- CISO N/A
- ASBP N/A
- 52 Week Low
- CISO $0.30
- ASBP $0.22
- 52 Week High
- CISO $3.84
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- CISO 72.95
- ASBP 42.62
- Support Level
- CISO $0.86
- ASBP $0.37
- Resistance Level
- CISO $1.32
- ASBP $0.47
- Average True Range (ATR)
- CISO 0.09
- ASBP 0.05
- MACD
- CISO 0.04
- ASBP -0.02
- Stochastic Oscillator
- CISO 91.23
- ASBP 21.64
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.